Emerald Advisers Decreased Xylem (XYL) Position; Stericycle (SRCL) Shorts Increased By 8.36%

May 16, 2018 - By Sheldon Barnett

Stericycle, Inc. (NASDAQ:SRCL) Logo

Emerald Advisers Inc decreased Xylem Inc (XYL) stake by 16.38% reported in 2017Q4 SEC filing. Emerald Advisers Inc sold 4,773 shares as Xylem Inc (XYL)’s stock rose 12.93%. The Emerald Advisers Inc holds 24,365 shares with $1.66 million value, down from 29,138 last quarter. Xylem Inc now has $12.84 billion valuation. The stock decreased 0.94% or $0.681 during the last trading session, reaching $71.389. About 287,401 shares traded. Xylem Inc. (NYSE:XYL) has risen 55.44% since May 16, 2017 and is uptrending. It has outperformed by 43.89% the S&P500.

Stericycle Inc (NASDAQ:SRCL) had an increase of 8.36% in short interest. SRCL’s SI was 6.22M shares in May as released by FINRA. Its up 8.36% from 5.74M shares previously. With 996,500 avg volume, 6 days are for Stericycle Inc (NASDAQ:SRCL)’s short sellers to cover SRCL’s short positions. The SI to Stericycle Inc’s float is 7.38%. The stock decreased 0.83% or $0.53 during the last trading session, reaching $63.34. About 99,176 shares traded. Stericycle, Inc. (NASDAQ:SRCL) has declined 27.78% since May 16, 2017 and is downtrending. It has underperformed by 39.33% the S&P500.

Investors sentiment increased to 1.08 in Q4 2017. Its up 0.07, from 1.01 in 2017Q3. It is positive, as 24 investors sold XYL shares while 186 reduced holdings. 59 funds opened positions while 167 raised stakes. 146.45 million shares or 0.34% less from 146.94 million shares in 2017Q3 were reported. Advantus Capital Mgmt Inc has invested 0.03% in Xylem Inc. (NYSE:XYL). Geode Capital Mgmt Limited Com has invested 0.05% in Xylem Inc. (NYSE:XYL). Mason Street Advisors Limited Liability Corporation holds 0.04% or 25,017 shares. Quantitative Systematic Strategies Limited Liability Corp has invested 0.1% of its portfolio in Xylem Inc. (NYSE:XYL). 54,169 are owned by Fjarde Ap. New Mexico Educational Retirement Board has 0.04% invested in Xylem Inc. (NYSE:XYL) for 17,255 shares. Covington Cap Mngmt reported 9,260 shares. Asset Mngmt One stated it has 0.06% of its portfolio in Xylem Inc. (NYSE:XYL). The Pennsylvania-based Glenmede Trust Comm Na has invested 0% in Xylem Inc. (NYSE:XYL). Tradewinds Cap Mgmt Ltd Liability Co invested 0% of its portfolio in Xylem Inc. (NYSE:XYL). Gam Holdg Ag reported 7,928 shares or 0.02% of all its holdings. Commercial Bank Of Nova Scotia has 28,155 shares for 0.01% of their portfolio. Patten & Patten Tn accumulated 14,100 shares or 0.1% of the stock. State Board Of Administration Of Florida Retirement Sys holds 0.05% or 271,817 shares in its portfolio. Highland Capital Mngmt Ltd Com reported 7,914 shares or 0.04% of all its holdings.

Among 20 analysts covering Xylem (NYSE:XYL), 12 have Buy rating, 0 Sell and 8 Hold. Therefore 60% are positive. Xylem had 78 analyst reports since August 3, 2015 according to SRatingsIntel. The rating was maintained by Stifel Nicolaus with “Hold” on Thursday, October 12. The stock has “Neutral” rating by Goldman Sachs on Wednesday, March 8. The rating was maintained by Boenning & Scattergood on Wednesday, June 7 with “Buy”. Robert W. Baird maintained Xylem Inc. (NYSE:XYL) rating on Tuesday, October 31. Robert W. Baird has “Hold” rating and $71.0 target. The stock of Xylem Inc. (NYSE:XYL) earned “Buy” rating by RBC Capital Markets on Monday, November 6. The firm earned “Buy” rating on Tuesday, June 20 by Oppenheimer. The rating was maintained by Stifel Nicolaus with “Hold” on Tuesday, July 4. Canaccord Genuity maintained Xylem Inc. (NYSE:XYL) on Thursday, July 27 with “Hold” rating. The rating was maintained by Susquehanna with “Hold” on Friday, January 12. Cowen & Co maintained Xylem Inc. (NYSE:XYL) rating on Wednesday, September 20. Cowen & Co has “Buy” rating and $70.0 target.

Emerald Advisers Inc increased Neogenomics Inc (NASDAQ:NEO) stake by 42,790 shares to 1.42M valued at $12.62M in 2017Q4. It also upped Us Concrete Inc (NASDAQ:USCR) stake by 27,146 shares and now owns 390,338 shares. Live Oak Bancshares Inc was raised too.

Analysts await Xylem Inc. (NYSE:XYL) to report earnings on August, 7. They expect $0.71 EPS, up 20.34% or $0.12 from last year’s $0.59 per share. XYL’s profit will be $127.74M for 25.14 P/E if the $0.71 EPS becomes a reality. After $0.51 actual EPS reported by Xylem Inc. for the previous quarter, Wall Street now forecasts 39.22% EPS growth.

Since December 11, 2017, it had 0 insider purchases, and 8 insider sales for $5.57 million activity. Shares for $13,373 were sold by LORANGER STEVEN R. Brannemo Tomas sold $87,948 worth of Xylem Inc. (NYSE:XYL) on Tuesday, February 27.

More notable recent Stericycle, Inc. (NASDAQ:SRCL) news were published by: Seekingalpha.com which released: “Stericycle: Looks To Have Turned The Corner” on May 15, 2018, also Globenewswire.com with their article: “Stericycle, Inc. Reports Results for the First Quarter 2018” published on May 03, 2018, Globenewswire.com published: “Stericycle to Participate in Two Investor Events” on April 18, 2018. More interesting news about Stericycle, Inc. (NASDAQ:SRCL) were released by: Seekingalpha.com and their article: “Stericycle, Inc. 2018 Q1 – Results – Earnings Call Slides” published on May 03, 2018 as well as Streetinsider.com‘s news article titled: “Stericycle (SRCL) PT Raised to $75 at Barrington Research, Says 2018 Outlook is Intact and Business Tranformation …” with publication date: May 14, 2018.

Among 16 analysts covering Stericycle (NASDAQ:SRCL), 6 have Buy rating, 2 Sell and 8 Hold. Therefore 38% are positive. Stericycle had 58 analyst reports since August 14, 2015 according to SRatingsIntel. Northcoast downgraded the stock to “Neutral” rating in Tuesday, September 20 report. Robert W. Baird maintained Stericycle, Inc. (NASDAQ:SRCL) rating on Tuesday, October 10. Robert W. Baird has “Sell” rating and $73.0 target. The rating was upgraded by Raymond James on Tuesday, September 8 to “Outperform”. The stock of Stericycle, Inc. (NASDAQ:SRCL) has “Underperform” rating given on Friday, September 9 by Imperial Capital. Goldman Sachs downgraded the stock to “Sell” rating in Thursday, November 3 report. On Tuesday, March 22 the stock rating was initiated by Sterne Agee CRT with “Buy”. The company was maintained on Friday, October 23 by Stifel Nicolaus. The firm earned “Neutral” rating on Tuesday, March 7 by Goldman Sachs. The firm has “Buy” rating given on Sunday, August 13 by Stifel Nicolaus. Oppenheimer initiated Stericycle, Inc. (NASDAQ:SRCL) on Thursday, November 9 with “Hold” rating.

Investors sentiment decreased to 0.7 in 2017 Q4. Its down 0.19, from 0.89 in 2017Q3. It dropped, as 75 investors sold Stericycle, Inc. shares while 177 reduced holdings. 50 funds opened positions while 126 raised stakes. 76.99 million shares or 1.32% less from 78.02 million shares in 2017Q3 were reported. Norinchukin Commercial Bank The owns 6,826 shares. Endurance Wealth has invested 0% in Stericycle, Inc. (NASDAQ:SRCL). Comerica Commercial Bank, Michigan-based fund reported 24,607 shares. Hartford Inv Management Company has invested 0.03% of its portfolio in Stericycle, Inc. (NASDAQ:SRCL). Choate Advsr reported 3,151 shares. Arizona State Retirement holds 0.01% or 21,630 shares in its portfolio. Barnett Com has invested 0.05% of its portfolio in Stericycle, Inc. (NASDAQ:SRCL). Moreover, Brown Advisory Inc has 0% invested in Stericycle, Inc. (NASDAQ:SRCL). State Of Tennessee Treasury Department stated it has 22,085 shares. Jnba Advisors holds 0.04% or 2,875 shares. 50 were accumulated by First Manhattan. Smith Graham And Invest Advisors L P has 0.59% invested in Stericycle, Inc. (NASDAQ:SRCL). Canada Pension Plan Invest Board, a Ontario – Canada-based fund reported 21 shares. Glg Prns Ltd Partnership stated it has 0% of its portfolio in Stericycle, Inc. (NASDAQ:SRCL). Covington Mngmt reported 50,695 shares or 0.21% of all its holdings.

Since March 1, 2018, it had 1 insider purchase, and 0 sales for $625,910 activity. SCHULER JACK W had bought 10,000 shares worth $625,910 on Thursday, March 1.

Stericycle, Inc., together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. The company has market cap of $5.42 billion. The firm collects and processes regulated and specialized waste for disposal services; and collects personal and confidential information for secure destruction, as well as offers training, consulting, recall/return, communication, and compliance services. It currently has negative earnings. The Company’s services and products include medical waste management, reusable sharps disposal management, pharmaceutical waste, and hazardous waste management services; integrated waste stream solutions program; sustainability and recycling services for expired or unused inventory; secure information destruction and hard drive destruction services; and regulated recall and returns management communication, logistics, and data management services for expired, withdrawn, or recalled products.

Xylem Inc. (NYSE:XYL) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: